Learning Objectives
Master the clinical applications of Liquid Biopsy. Understand the role of ctDNA, ctRNA, and CTCs in cancer profiling, treatment monitoring, and early metastatic detection, providing a noninvasive alternative to traditional tissue biopsies.
1. What is a Liquid Biopsy?
A liquid biopsy is a noninvasive diagnostic test performed on body fluids—most commonly blood or urine. It allows for the detection of molecular markers shed by a tumor into the systemic circulation.
| Component | Abbreviation | Description |
|---|---|---|
| Circulating Tumor DNA | ctDNA | Small fragments of DNA are released by dying tumor cells. |
| Circulating Tumor Cells | CTCs | Intact malignant cells that have detached from the primary tumor. |
| Circulating Tumor RNA | ctRNA | RNA molecules are used for gene expression profiling. |
2. Clinical Applications
Liquid biopsies provide a “real-time” look at a tumor’s genetic landscape, which is essential for personalized therapy and long-term management.
| Application | Example |
|---|---|
| Cancer Profiling | Identifying EGFR mutations in non-small cell lung cancer (NSCLC) to guide targeted therapy. |
| Treatment Monitoring | Tracking ctDNA levels to see if a chemotherapy or immunotherapy is working. |
| Surveillance | Detecting minimal residual disease in colorectal cancer after surgery. |
| Early Detection | Aiding in the detection of metastatic spread before it becomes visible on traditional imaging. |
Activity:
Activity
High-Yield Mnemonics & Tips:
- Tissue vs. Liquid: While tissue biopsy remains the gold standard for initial diagnosis, liquid biopsy is superior for capturing tumor heterogeneity (different mutations in different parts of the tumor).
- Minimal Residual Disease (MRD): Think of liquid biopsy as a highly sensitive “bloodhound” that can sniff out cancer DNA long before a CT scan shows a 1 cm mass.
- EGFR in Lung: This is the most “Step-relevant” clinical example. If a patient’s lung tumor is hard to reach for a needle biopsy, doctors often check the blood for EGFR mutations.